About RheumaGen
RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Aurora, United States
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
rheumagen.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised undisclosed · Series-A
fundraisingfox.com
- Capital Raise
Raised $15,000,000 · Series-A
fundraisingfox.com
Investors & Backers
Beyond Celiac Investments
SPRIM Global Investments
William Taylor Nominees
Funding History
Series-A equity
· Dec 22, 2025
undisclosed fundraisingfox.com
Series-A equity
· Jan 9, 2025
$15,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026